Anoto Digital Pen and Paper technology automatically stores what a user writes or draws. The pen records what is being written on to a form, printed with the Anoto special dot pattern. These data are transmitted back to a PC or server—via a docking station or a mobile phone—without the need to type up notes.
Actelion Pharmaceuticals’ clinical trial investigators use data collected from the Anoto Digital Pen on a daily basis in order to adjust drug dosages of Tracleer, a drug for Pulmonary Arterial Hypetension (PAH) that is given to patients to attain successful clinical trials faster, easier, and more closely monitored.
Published in Drug Discovery & Development magazine: Vol. 10, No. 10, October, 2007, p. 42.
Filed Under: Drug Discovery